Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease.

Elliott TR, Rayment NB, Hudspith BN, Hands RE, Taylor K, Parkes GC, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Bustin SA, Sanderson JD.

BMC Gastroenterol. 2015 Jul 3;15:75. doi: 10.1186/s12876-015-0305-3.

2.

Defective macrophage handling of Escherichia coli in Crohn's disease.

Elliott TR, Hudspith BN, Rayment NB, Prescott NJ, Petrovska L, Hermon-Taylor J, Brostoff J, Boussioutas A, Mathew CG, Sanderson JD.

J Gastroenterol Hepatol. 2015 Aug;30(8):1265-74. doi: 10.1111/jgh.12955.

PMID:
25809337
3.

Effect of breadmaking process on in vitro gut microbiota parameters in irritable bowel syndrome.

Costabile A, Santarelli S, Claus SP, Sanderson J, Hudspith BN, Brostoff J, Ward JL, Lovegrove A, Shewry PR, Jones HE, Whitley AM, Gibson GR.

PLoS One. 2014 Oct 30;9(10):e111225. doi: 10.1371/journal.pone.0111225. eCollection 2014.

4.

Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.

Elliott TR, Hudspith BN, Wu G, Cooley M, Parkes G, QuiƱones B, Randall L, Mandrell RE, Fagerquist CK, Brostoff J, Rayment NB, Boussioutas A, Petrovska L, Sanderson JD.

Inflamm Bowel Dis. 2013 Oct;19(11):2326-38. doi: 10.1097/MIB.0b013e3182a38a92.

PMID:
23989750
5.

Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer MC, Brostoff J, Whelan K, Sanderson JD.

Neurogastroenterol Motil. 2012 Jan;24(1):31-9. doi: 10.1111/j.1365-2982.2011.01803.x. Epub 2011 Nov 9.

PMID:
22070725
6.

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.

Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L.

BMC Microbiol. 2011 Jan 10;11:7. doi: 10.1186/1471-2180-11-7.

8.

Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J.

Inflamm Bowel Dis. 2005 May;11(5):481-7.

PMID:
15867588
10.

Immunotoxicology: extrapolation from animal to man--estimation of the immunotoxicologic risk associated with TBTO exposure.

Van Loveren H, Slob W, Vandebriel RJ, Hudspith BN, Meredith C, Garssen J.

Arch Toxicol Suppl. 1998;20:285-92.

PMID:
9442301
11.

Secretory and accessory cell functions of the alveolar macrophage.

Miller K, Hudspith BN, Meredith C.

Environ Health Perspect. 1992 Jul;97:85-9.

12.

Lithium counteracts histamine suppression of human T cell mitogenesis.

Hall TJ, Heckel C, Hudspith BN, Brostoff J.

Immunol Lett. 1990 May;24(2):103-5.

PMID:
2162327
13.

Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues.

Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J.

Immunopharmacology. 1990 Mar-Apr;19(2):87-91.

PMID:
2161808
14.

Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo.

Murphy GM, Dowd PM, Hudspith BN, Brostoff J, Greaves MW.

Photodermatol. 1989 Dec;6(6):268-74.

PMID:
2636982
15.

Bronchoalveolar lavage cell counts as a predictor of short term outcome in pulmonary sarcoidosis.

Foley NM, Coral AP, Tung K, Hudspith BN, James DG, Johnson NM.

Thorax. 1989 Sep;44(9):732-8.

16.

Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors.

Hucklebridge FH, Hudspith BN, Muhamed J, Lydyard PM, Brostoff J.

Brain Behav Immun. 1989 Jun;3(2):183-9.

PMID:
2551418
17.

Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations.

Pearce FL, Al-Laith M, Bosman L, Brostoff J, Cunniffe TM, Flint KC, Hudspith BN, Jaffar ZH, Johnson NM, Kassessinoff TA, et al.

Drugs. 1989;37 Suppl 1:37-43; discussion 69-77.

PMID:
2474428
18.

Nasal histamine release following hyperosmolar and allergen challenge.

Krayenbuhl MC, Hudspith BN, Brostoff J, Scadding GK, Guesdon JL, Latchman Y.

Allergy. 1989 Jan;44(1):25-9.

PMID:
2470266
19.

Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.

Leung KB, Flint KC, Brostoff J, Hudspith BN, Johnson NM, Lau HY, Liu WL, Pearce FL.

Thorax. 1988 Oct;43(10):756-61.

20.

Nasal response to allergen and hyperosmolar challenge.

Krayenbuhl MC, Hudspith BN, Scadding GK, Brostoff J.

Clin Allergy. 1988 Mar;18(2):157-64.

PMID:
3365859
21.

Serum C-reactive protein concentrations in patients with pulmonary sarcoidosis.

Hind CR, Flint KC, Hudspith BN, Felmingham D, Brostoff J, Johnson NM.

Thorax. 1987 May;42(5):332-5.

22.

Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response.

Hudspith BN, Flint KC, Geraint-James D, Brostoff J, Johnson NM.

Thorax. 1987 Apr;42(4):250-5.

23.

Some further properties of human pulmonary mast cells recovered by bronchoalveolar lavage and enzymic dispersion of lung tissue.

Leung KB, Flint KC, Hudspith BN, Brostoff J, Johnson NM, Seager K, Hammond MD, Pearce FL.

Agents Actions. 1987 Apr;20(3-4):213-5.

PMID:
2440274
24.

Release in vivo of IL-1 like activity by human skin.

Dowd PM, Hudspith BN, Miller JA, Barr RM, Brostoff J, Greaves MW.

Clin Exp Immunol. 1987 Mar;67(3):606-10.

25.

Modulation of cutaneous interleukin-1 (IL-1)-like activity by endogenously produced eicosanoids.

Dowd PM, Barr RM, Hudspith BN, Miller JA, Brostoff J, Greaves MW.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:664-7. No abstract available.

PMID:
2960173
26.

Increased natural killer cell activity in sarcoidosis.

Hall TJ, Hudspith BN, Johnson NM, Brostoff J.

Int Arch Allergy Appl Immunol. 1987;82(1):10-6.

PMID:
2948920
27.

Some studies on human pulmonary mast cells obtained by bronchoalveolar lavage and by enzymic dissociation of whole lung tissue.

Pearce FL, Flint KC, Leung KB, Hudspith BN, Seager K, Hammond MD, Brostoff J, Geraint-James D, Johnson NM.

Int Arch Allergy Appl Immunol. 1987;82(3-4):507-12.

PMID:
2437052
28.

Some properties of mast cells obtained by human bronchoalveolar lavage.

Leung KB, Flint KC, Brostoff J, Hudspith BN, Johnson NM, Pearce FL.

Agents Actions. 1986 Apr;18(1-2):110-2.

PMID:
2425569
29.

Bronchoalveolar mast cells in sarcoidosis: increased numbers and accentuation of mediator release.

Flint KC, Leung KB, Hudspith BN, Brostoff J, Pearce FL, Geraint-James D, Johnson NM.

Thorax. 1986 Feb;41(2):94-9.

30.

The function and properties of human lung mast cells.

Flint KC, Leung KB, Hudspith BN, Pearce FL, Brostoff J, Johnson NM.

Respiration. 1986;50 Suppl 2:31-41.

PMID:
3105016
31.

A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.

Leung KB, Flint KC, Brostoff J, Hudspith BN, Johnson NM, Pearce FL.

Eur J Respir Dis Suppl. 1986;147:223-6.

PMID:
2429855
32.

Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction.

Flint KC, Leung KB, Hudspith BN, Brostoff J, Pearce FL, Johnson NM.

Br Med J (Clin Res Ed). 1985 Oct 5;291(6500):923-6.

33.

Sarcoidosis is not associated with the HTLV III virus.

Flint KC, Hudspith BN, Chiensong-Popou R, Tedder R, James DG, Johnson NM.

Sarcoidosis. 1985 Sep;2(2):157.

PMID:
3855174
34.

Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate.

Flint KC, Leung KB, Pearce FL, Hudspith BN, Brostoff J, Johnson NM.

Clin Sci (Lond). 1985 Apr;68(4):427-32.

PMID:
2578914
35.

Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.

Hudspith BN, Brostoff J, McNicol MW, Johnson NM.

Clin Exp Immunol. 1984 Aug;57(2):324-30.

36.

Intrinsic and extrinsic asthma, a shared lymphocyte abnormality.

Swinburn CR, Hudspith BN, Brostoff J, Johnson NM.

Clin Allergy. 1983 Nov;13(6):571-6.

PMID:
6640893
37.
38.

Prostaglandin E2-mediated enhancement of human plasma cell differentiation.

Lydyard PM, Brostoff J, Hudspith BN, Parry H.

Immunol Lett. 1982 Mar;4(3):113-6.

PMID:
6210627
39.
40.

T gamma cells in sarcoidosis: E rosetting monocytes suppress lymphocyte transformation.

Johnson NM, Brostoff J, Hudspith BN, Boot JR, McNicol MW.

Clin Exp Immunol. 1981 Mar;43(3):491-6.

41.

Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents.

Millar JL, Blackett NM, Hudspith BN.

Cell Tissue Kinet. 1978 Sep;11(5):543-53.

PMID:
719696
42.

Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide.

Millar JL, Hudspith BN, McElwain TJ, Phelps TA.

Br J Cancer. 1978 Jul;38(1):137-42.

43.
44.

Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.

Millar JL, Hudspith BN, Blackett NM.

Br J Cancer. 1975 Aug;32(2):193-8.

Supplemental Content

Loading ...
Support Center